Study of LFD-200 in Healthy Adults and Adults With Moderate to Severe Rheumatoid Arthritis
Clinical trial NCT07207954 · RECRUITING
Trial details
- NCT number
- NCT07207954
- Sponsor
- Lifordi Immunotherapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-06
- Primary completion
- 2027-07-16
- Enrollment
- 176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.